Anna Robelius

Somatic Exonic Deletions in RUNX1 Constitutes a Novel Recurrent Genomic Abnormality in Acute Myeloid Leukemia

Eriksson, Anna; Engvall, Marie; Mathot, Lucy; Österroos, Albin et al.

Ingår i Clinical Cancer Research, s. 2826-2834, 2023

• DOI för Somatic Exonic Deletions in RUNX1 Constitutes a Novel Recurrent Genomic Abnormality in Acute Myeloid Leukemia

Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children

Stratmann, Svea; Vesterlund, Mattias; Umer, Husen M.; Skaftason, Aron et al.

Ingår i Leukemia, s. 550-559, 2023

• DOI för Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children
• Ladda ner fulltext (pdf) av Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children

Managing leukemia patients via liquid biopsy and super rolling circle amplification (superRCA)

Robelius, Anna; Chen, Lei; Amini, Rose-Marie; Cavelier, Lucia et al.

Ingår i Journal of Internal Medicine, s. 228-237, 2023

• DOI för Managing leukemia patients via liquid biopsy and super rolling circle amplification (superRCA)

Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications

Nilsson, Christer; Linde, Fredrika; Hulegardh, Erik; Garelius, Hege et al.

Ingår i Haematologica, s. 1015-1025, 2023

• DOI för Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications
• Ladda ner fulltext (pdf) av Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications

Is it possible to increase the amount of physical activity in patients isolated due to hematopoietic stem cell transplantation using a nursing intervention?: A feasibility study

Vejby, Sölvi; Eriksson, Anna; Nordin, Karin; Johansson, Birgitta

Ingår i Nordic journal of nursing research, s. 18-27, 2022

• DOI för Is it possible to increase the amount of physical activity in patients isolated due to hematopoietic stem cell transplantation using a nursing intervention?: A feasibility study
• Ladda ner fulltext (pdf) av Is it possible to increase the amount of physical activity in patients isolated due to hematopoietic stem cell transplantation using a nursing intervention?: A feasibility study

Somatic Exonic Deletions in RUNX1 Constitutes a Novel Recurrent Genomic Abnormality in Acute Myeloid Leukemia

Eriksson, Anna; Engvall, Marie; Mathot, Lucy; Österroos, Albin et al.

Ingår i Clinical Cancer Research, s. 2826-2834, 2023

• DOI för Somatic Exonic Deletions in RUNX1 Constitutes a Novel Recurrent Genomic Abnormality in Acute Myeloid Leukemia

Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children

Stratmann, Svea; Vesterlund, Mattias; Umer, Husen M.; Skaftason, Aron et al.

Ingår i Leukemia, s. 550-559, 2023

• DOI för Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children
• Ladda ner fulltext (pdf) av Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children

Managing leukemia patients via liquid biopsy and super rolling circle amplification (superRCA)

Robelius, Anna; Chen, Lei; Amini, Rose-Marie; Cavelier, Lucia et al.

Ingår i Journal of Internal Medicine, s. 228-237, 2023

• DOI för Managing leukemia patients via liquid biopsy and super rolling circle amplification (superRCA)

Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications

Nilsson, Christer; Linde, Fredrika; Hulegardh, Erik; Garelius, Hege et al.

Ingår i Haematologica, s. 1015-1025, 2023

• DOI för Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications
• Ladda ner fulltext (pdf) av Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications

Is it possible to increase the amount of physical activity in patients isolated due to hematopoietic stem cell transplantation using a nursing intervention?: A feasibility study

Vejby, Sölvi; Eriksson, Anna; Nordin, Karin; Johansson, Birgitta

Ingår i Nordic journal of nursing research, s. 18-27, 2022

• DOI för Is it possible to increase the amount of physical activity in patients isolated due to hematopoietic stem cell transplantation using a nursing intervention?: A feasibility study
• Ladda ner fulltext (pdf) av Is it possible to increase the amount of physical activity in patients isolated due to hematopoietic stem cell transplantation using a nursing intervention?: A feasibility study

Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression

Stratmann, Svea; Yones, Sara A.; Garbulowski, Mateusz; Sun, Jitong et al.

Ingår i Blood Advances, s. 152-164, 2022

• DOI för Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression
• Ladda ner fulltext (pdf) av Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression

A risk score based on real-world data to predict early death in acute promyelocytic leukemia

Österroos, Albin; Maia, Tania; Eriksson, Anna; Jädersten, Martin et al.

Ingår i Haematologica, s. 1528-1537, 2022

• DOI för A risk score based on real-world data to predict early death in acute promyelocytic leukemia
• Ladda ner fulltext (pdf) av A risk score based on real-world data to predict early death in acute promyelocytic leukemia

Plasma protein biomarker profiling reveals major differences between acute leukaemia, lymphoma patients and controls

Sabaa, Amal Abu; Shen, Qiujin; Lennmyr, Emma; Enblad, Anna Pia et al.

Ingår i New Biotechnology, s. 21-29, 2022

• DOI för Plasma protein biomarker profiling reveals major differences between acute leukaemia, lymphoma patients and controls
• Ladda ner fulltext (pdf) av Plasma protein biomarker profiling reveals major differences between acute leukaemia, lymphoma patients and controls

Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets

Stratmann, Svea; Yones, Sara A.; Mayrhofer, Markus; Norgren, Nina et al.

Ingår i Blood Advances, s. 900-912, 2021

• DOI för Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets

Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AML

Mareschal, Sylvain; Palau, Anna; Lindberg, Johan; Ruminy, Philippe et al.

Ingår i Blood Advances, s. 1003-1016, 2021

• DOI för Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AML

Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma

Mörth, Charlott; Sabaa, Amal Abu; Freyhult, Eva; Christersson, Christina et al.

Ingår i Cardio-Oncology, 2021

• DOI för Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma
• Ladda ner fulltext (pdf) av Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma

Integrated transcriptomic and genomic analysis improves prediction of complete remission and survival in elderly patients with acute myeloid leukemia

Österroos, Albin; Björklund, My; Eriksson, Anna; Lindberg, Johan et al.

Ingår i Blood Cancer Journal, 2020

• DOI för Integrated transcriptomic and genomic analysis improves prediction of complete remission and survival in elderly patients with acute myeloid leukemia
• Ladda ner fulltext (pdf) av Integrated transcriptomic and genomic analysis improves prediction of complete remission and survival in elderly patients with acute myeloid leukemia

Real-world data on treatment patterns and outcomes of hypomethylating therapy in patients with newly diagnosed acute myeloid leukaemia aged ≥ 60 years

Österroos, Albin; Eriksson, Anna; Antunovic, Petar; Cammenga, Jörg et al.

Ingår i British Journal of Haematology, 2020

• DOI för Real-world data on treatment patterns and outcomes of hypomethylating therapy in patients with newly diagnosed acute myeloid leukaemia aged ≥ 60 years

Towards repositioning of quinacrine for treatment of acute myeloid leukemia - Promising synergies and in vivo effects.

Eriksson, Anna; Chantzi, Efthymia; Fryknäs, Mårten; Gullbo, Joachim et al.

Ingår i Leukemia Research, s. 41-46, 2017

• DOI för Towards repositioning of quinacrine for treatment of acute myeloid leukemia - Promising synergies and in vivo effects.
• Ladda ner fulltext (pdf) av Towards repositioning of quinacrine for treatment of acute myeloid leukemia - Promising synergies and in vivo effects.

Combination screening in vitro identifies synergistically acting KP372-1 and cytarabine against acute myeloid leukemia

Österroos, Albin; Kashif, Muhammad; Haglund, Caroline; Blom, Kristin et al.

Ingår i Biochemical Pharmacology, s. 40-49, 2016

• DOI för Combination screening in vitro identifies synergistically acting KP372-1 and cytarabine against acute myeloid leukemia

Repositioning Of Quinacrine For Treatment Of Acute Myeloid Leukemia - Synergies And In Vivo Effects

Eriksson, Anna; Gustafsson, Mats; Fryknäs, Mårten; Gullbo, Joachim et al.

Ingår i Haematologica, s. 367-368, 2016

Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia

Eriksson, Anna; Österroos, Albin; Hassan, Sadia Bashir; Gullbo, Joachim et al.

Ingår i Blood Cancer Journal, 2015

• DOI för Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia
• Ladda ner fulltext (pdf) av Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia

Development of a Progress Test Based on the EHA Curriculum and EHA CV Passport, Used for Yearly Evaluation of Hematology Residency In Sweden

Ungerstedt, J.; Eriksson, Anna; Olander, E.; Bergfelt, Emma et al.

Ingår i Haematologica, s. 776-776, 2015

Epigenetic aberrations in acute myeloid leukemia: Early key events during leukemogenesis

Eriksson, Anna; Lennartsson, Andreas; Lehmann, Sören

Ingår i Experimental Hematology, s. 609-624, 2015

• DOI för Epigenetic aberrations in acute myeloid leukemia: Early key events during leukemogenesis

Development of Progress Test Based on EHA Curriculum and EHA CV Passport, Used for Yearly Evaluation of Hematology Residency in Sweden

Ungerstedt, J.; Eriksson, Anna; Olander, E.; Theander, J. et al.

Ingår i Haematologica, s. 788-788, 2014

AKN-028 induces cell cycle arrest, downregulation of Myc associated genes and a dose dependent reduction of kinase activity in acute myeloid leukemia

Eriksson, Anna; Kalushkova, Antonia; Jarvius, Malin; Hilhorst, Riet et al.

Ingår i Biochemical Pharmacology, s. 284-291, 2014

• DOI för AKN-028 induces cell cycle arrest, downregulation of Myc associated genes and a dose dependent reduction of kinase activity in acute myeloid leukemia
• Ladda ner fulltext (pdf) av AKN-028 induces cell cycle arrest, downregulation of Myc associated genes and a dose dependent reduction of kinase activity in acute myeloid leukemia

Repositioning of Quinacrine for Treatment of Acute Myeloid Leukemia

Eriksson, Anna; Osterros, Albin; Hassan, Sadia Bashir; Gullbo, Joachim et al.

Ingår i Blood, 2014

The novel tyrosine kinase inhibitor AKN-028 has significant antileukemic activity in cell lines and primary cultures of acute myeloid leukemia

Eriksson, Anna; Hermanson, Monica; Wickström, Malin; Lindhagen, Elin et al.

Ingår i Blood Cancer Journal, 2012

• DOI för The novel tyrosine kinase inhibitor AKN-028 has significant antileukemic activity in cell lines and primary cultures of acute myeloid leukemia

Identification of AKN-032, a novel 2-aminopyrazine tyrosine kinase inhibitor, with significant preclinical activity in acute myeloid leukemia

Eriksson, Anna; Höglund, Martin; Lindhagen, Elin; Åleskog, Anna et al.

Ingår i Biochemical Pharmacology, s. 1507-1516, 2010

• DOI för Identification of AKN-032, a novel 2-aminopyrazine tyrosine kinase inhibitor, with significant preclinical activity in acute myeloid leukemia

SUPPLEMENTARY MATERIAL: Transcriptomic analysis reveals pro-inflammatory signatures associated with acute myeloid leukemia progression

Stratmann, Svea; Yones, Sara A.; Garbulowski, Mateusz; Sun, Jitong et al.

2021

SUPPLEMENTAL INFORMATION FOR: Transcriptomic analysis reveals pro-inflammatory signatures associated with acute myeloid leukemia progression

Stratmann, Svea; Yones, Sara A.; Garbulowski, Mateusz; Sun, Jitong et al.

2020

• Ladda ner fulltext (pdf) av SUPPLEMENTAL INFORMATION FOR: Transcriptomic analysis reveals pro-inflammatory signatures associated with acute myeloid leukemia progression

Studies of New Signal Transduction Modulators in Acute Myeloid Leukemia

Eriksson, Anna

2012

• Ladda ner fulltext (pdf) av Studies of New Signal Transduction Modulators in Acute Myeloid Leukemia

Integrated multi-omic profiling of azacitidine-venetoclax in AML reveals additional targetable pathways to improve the treatment

Österroos, Albin; Zhong, Xiangfu; Gamboa Cedeno, Angelica; Junkunlo, Kingkamon et al.

T-cell Leukaemia/Lymphoma Protein 1A (TCL1A) In Diffuse Large B-cell lymphoma (DLBCL)

Abu Sabaa, Amal; Mörth, Charlott; Berglund, Mattias; Hashemi, Jamileh et al.

Plasma Protein Profiling using Multiplex Extension Assay in Diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP: A descriptive study

Abu Sabaa, Amal; Mörth, Charlott; Molin, Daniel; Freyhult, Eva et al.